Exploring reasons behind patient compliance with nutrition supplements before pelvic exenteration surgery.


Journal

Supportive care in cancer : official journal of the Multinational Association of Supportive Care in Cancer
ISSN: 1433-7339
Titre abrégé: Support Care Cancer
Pays: Germany
ID NLM: 9302957

Informations de publication

Date de publication:
May 2019
Historique:
received: 23 01 2018
accepted: 26 08 2018
pubmed: 7 9 2018
medline: 8 6 2019
entrez: 7 9 2018
Statut: ppublish

Résumé

Compliance with oral nutrition support (ONS) is poorly reported in the literature. Many factors influence compliance, which could mask the true benefits of preoperative ONS. Surgical oncology patients, including pelvic exenteration patients, are often requested by healthcare workers to consume nutrition supplements before surgery. Exploration of barriers and enablers to compliance with nutrition supplements is needed to improve patient compliance and understand the real impact of preoperative ONS. A qualitative study using semi-structured interviews was performed to investigate enablers and barriers to preoperative nutrition supplement compliance. Twenty participants who had been asked to consume 15 nutrition supplements, either immunonutrition or standard polymeric supplements, were interviewed. Inductive thematic analysis was used to determine major themes associated with compliance. Twelve out of 20 participants were not compliant with recommended dosing. Well-nourished participants were more compliant than malnourished participants. Major themes associated with compliance were flavour, volume, texture, impact on dietary intake and motivation to consume supplements. Flavour differed between the two groups, negatively impacting compliance in the immunonutrition group. Volume, texture and impact on dietary intake also negatively impacted compliance whereas motivation positively impacted compliance. To overcome barriers and enforce enablers with nutrition supplement compliance, it is essential healthcare workers implement individualised interventions, taking into account nutritional status. A range of flavours, minimal volume and low viscosity supplements should be provided to address individual preference and minimise poor compliance. Better-targeted education and regular motivation are needed to improve compliance.

Identifiants

pubmed: 30187221
doi: 10.1007/s00520-018-4445-1
pii: 10.1007/s00520-018-4445-1
doi:

Types de publication

Journal Article Randomized Controlled Trial

Langues

eng

Sous-ensembles de citation

IM

Pagination

1853-1860

Références

Physiol Behav. 2001 Nov-Dec;74(4-5):551-7
pubmed: 11790415
Health Serv Res. 1999 Dec;34(5 Pt 2):1189-208
pubmed: 10591279
J Surg Res. 2017 Oct;218:167-173
pubmed: 28985845
Clin Nutr. 2008 Jun;27(3):340-9
pubmed: 18504063
Clin Nutr. 2012 Jun;31(3):293-312
pubmed: 22257636
Clin Nutr. 2017 Feb;36(1):11-48
pubmed: 27637832
Colorectal Dis. 2017 May;19(5):430-436
pubmed: 28267255
Clin Nutr. 2010 Apr;29(2):160-9
pubmed: 19828215
Clin Nutr. 2008 Aug;27(4):660-5
pubmed: 18625541
Lipids. 2012 Dec;47(12):1169-79
pubmed: 23096224
J Am Coll Nutr. 2004 Jun;23(3):227-32
pubmed: 15190047
Br J Surg. 2014 Feb;101(3):277-87
pubmed: 24420909
J Sci Food Agric. 2018 Mar;98(5):1647-1652
pubmed: 29168190
Support Care Cancer. 2015 Feb;23(2):365-70
pubmed: 25091056
Br J Surg. 2010 Jan;97(1):92-7
pubmed: 20013933
J Am Coll Surg. 2011 Mar;212(3):385-99, 399.e1
pubmed: 21247782
J Am Diet Assoc. 2004 Jul;104(7):1151-3
pubmed: 15215775
Surg Infect (Larchmt). 2018 Jan;19(1):1-10
pubmed: 29049000
Dis Colon Rectum. 2017 Jul;60(7):745-754
pubmed: 28594725
Dis Colon Rectum. 2017 Jan;60(1):68-75
pubmed: 27926559
Eur J Clin Nutr. 2013 Aug;67(8):802-7
pubmed: 23801093
Dis Colon Rectum. 2010 Aug;53(8):1121-6
pubmed: 20628274
Ther Clin Risk Manag. 2008 Feb;4(1):269-86
pubmed: 18728716
Dis Colon Rectum. 2013 Apr;56(4):519-31
pubmed: 23478621
J Am Coll Surg. 2014 Nov;219(5):1078-87
pubmed: 25260681
Cochrane Database Syst Rev. 2012 Nov 14;11:CD008879
pubmed: 23152265
J Clin Epidemiol. 2006 Jul;59(7):704-9
pubmed: 16765273
Support Care Cancer. 2016 Oct;24(10):4301-8
pubmed: 27220522

Auteurs

Sophie E Hogan (SE)

Royal Prince Alfred Hospital, Sydney, NSW, Australia. sophie.hogan@health.nsw.gov.au.

Michael J Solomon (MJ)

Royal Prince Alfred Hospital, Sydney, NSW, Australia.
University of Sydney, Sydney, NSW, Australia.

Sharon K Carey (SK)

Royal Prince Alfred Hospital, Sydney, NSW, Australia.
University of Sydney, Sydney, NSW, Australia.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH